The latest insights from experts at Niederer Kraft Frey.
Drug & Medical Device Litigation 2026: Switzerland Chapter
Produkthaftung 4.0
Mitwirkungspflichten im FINMA-Enforcementverfahren und Verwertbarkeit in Strafverfahren
War on Drugs mit Instrumenten der Terrorismusbekämpfung: Was bedeutet das für die Compliance?
FINMA-Auskünfte ohne nemo-tenetur-Hinweis sind strafrechtlich nicht verwendbar (Bundesgerichtsurteil ...
Kritik aus Strassburgund Luxemburg
Information Rights in the Law of Corporations and LLCs
Legal and Regulatory Framework of Board Work
The moving boundaries of arbitrability in the Life Sciences sector: is there any room for ADR in produ...
Performance meets payoff: Crafting win-win earnout agreements
Online influencers, digital media, and pharmaceutical advertisement
Distribution Agreements: A Cross-Perspective Between Commercial Strategy and Litigation
Planned Tightening of Lex Koller Rules
Switzerland Moves to Regulate Space Operations — A New Legal Orbit for the Swiss Space Industry
New limits for use of supervisory information in criminal proceedings
Amendment to the Swiss Telecommunications Surveillance Laws Application Scope: Opening of Public Consu...
The EU AI Act Enters into Force: Implications for Swiss Companies
Competition Commission (COMCO) rules for the first time in a case on relative market power – COMCO d...
